L390-2630 Screening compound: 1-[7-(2H-1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine

L390-2630 Screening compound: 1-[7-(2H-1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine
L390-2630 Screening compound: 1-[7-(2H-1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L390-2630
1-[7-(2H-1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L390-2630

Molecular Formula

C24H20ClN5O3 (C24 H20 ClN5 O3)

Compound Name

1-[7-(2H-1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine

IUPAC name

1-[7-(2H-13-benzodioxol-5-yl)pyrazolo[15-a]pyrimidine-3-carbonyl]-4-(3-chlorophenyl)piperazine

SMILES

O=C(c1c2nccc(-c(cc3)cc4c3OCO4)n2nc1)N(CC1)CCN1c1cccc(Cl)c1

InChI

InChI=1S/C24H20ClN5O3/c25-17-2-1-3-18(13-17)28-8-10-29(11-9-28)24(31)19-14-27-30-20(6-7-26-23(19)30)16-4-5-21-22(12-16)33-15-32-21/h1-7,12-14H,8-11,15H2

InChI Key

CQQOIDHQHBJZGG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20736331

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.91

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.773

Distribution Coefficient, logD

3.773

Water Solubility, LogSw

-4.24

Polar Surface Area

56.624

Acid Dissociation Constant (pKa)

27.18

Base Dissociation Constant (pKb)

1.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

L390-2630 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with L390-2630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L390-2630?
Check Price and Availability of L390-2630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L390-2630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L390-2630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L390-2630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L390-2630 available by request